Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
Haleh Rezaee, Fariba Pourkarim, Samira Pourtaghi‐Anvarian, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Molnupiravir: A new candidate for COVID‐19 treatment
Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Haleh Rezaee
Pharmacology Research & Perspectives (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 113
Antifungal Drugs TDM: Trends and Update
Benjamin Kably, Manon Launay, Audrey Derobertmasure, et al.
Therapeutic Drug Monitoring (2021) Vol. 44, Iss. 1, pp. 166-197
Closed Access | Times Cited: 50
Variable effects of underlying diseases on the prognosis of patients with COVID-19
Yong Jun Choi, Juyoung Park, Hye Sun Lee, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0254258-e0254258
Open Access | Times Cited: 34
Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey
Ebuwa Igho-Osagie, Kaylen Brzozowski, Harry Jin, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 5, pp. 390-399.e4
Open Access | Times Cited: 14
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Innovative Molecularly Imprinted Electrochemical Sensor for Selective Nanomolar Detection of the Anti-COVID-19 Medication Molnupiravir
Rania A. Sayed, Manal S. Elmasry, Asmaa M. Taha, et al.
Journal of The Electrochemical Society (2024) Vol. 171, Iss. 6, pp. 067507-067507
Closed Access | Times Cited: 4
Inappropriate polypharmacy during the COVID-19 pandemic: impact, challenges, and solutions – a narrative review
Evelina Gavazova, Radiana Staynova, Daniela Grekova
Folia Medica (2025) Vol. 67, Iss. 1
Open Access
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
Paul Biever, Dawid L. Staudacher, Michaela J. Sommer, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 15
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis, Πέτρος Ιωάννου, Sotiris Tzalis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7172-7172
Open Access | Times Cited: 9
COVID-19-Associated Acute Psychotic Disorder—Longitudinal Case Report and Brief Review of Literature
Maria Gabriela Puiu, Vlad Dionisie, Andra Ioana Dobrin, et al.
Medicina (2023) Vol. 59, Iss. 2, pp. 408-408
Open Access | Times Cited: 5
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
Marios Spanakis, Athina Patelarou, Evridiki Patelarou, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 21, pp. 11711-11711
Open Access | Times Cited: 12
In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir
Qingchen Zhang, Philip W. Melchert, John S. Markowitz
Chemico-Biological Interactions (2022) Vol. 365, pp. 110097-110097
Open Access | Times Cited: 8
The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients
Thien Khac Nguyen, Giang Minh Vu, Vinh Chi Duong, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27043-e27043
Open Access | Times Cited: 1
Can Anti-Parasitic Drugs Help Control COVID-19?
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, et al.
Future Virology (2022) Vol. 17, Iss. 5, pp. 315-339
Open Access | Times Cited: 7
Scoping insight on antiviral drugs against COVID-19
Ahmed S. Ali, Ibrahim M. Ibrahim, Abdulhadi S. Burzangi, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 10, pp. 103385-103385
Open Access | Times Cited: 9
A New Chemometrically Assisted UV Spectrophotometric Method for Simultaneous Determination of Tamsulosin and Dutasteride in Their Pharmaceutical Mixture
Khalid A.M. Attia, Ahmed Serag, Sherif M. Eid, et al.
Journal of AOAC International (2022) Vol. 105, Iss. 6, pp. 1755-1761
Open Access | Times Cited: 6
Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Mehdi Rasouli, Fatemeh Vakilian, Javad Ranjbari
Current Stem Cell Research & Therapy (2020) Vol. 17, Iss. 2, pp. 166-185
Closed Access | Times Cited: 7
Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
Türkan Paşalı Kilit, Filiz Özyiğit, Sertaş Erarslan, et al.
African Health Sciences (2022) Vol. 22, Iss. 4, pp. 597-606
Open Access | Times Cited: 4
THE IMPACT OF INFLAMMATION AND DRUG INTERACTIONS ON COVID-19 PHARMACOTHERAPY. A MINI-REVIEW
MONICA NEAMȚU
FARMACIA (2022) Vol. 70, Iss. 5, pp. 775-784
Open Access | Times Cited: 4
Statins in COVID-19 Therapy
Justyna Olszewska-Parasiewicz, Łukasz Szarpak, Sylwester Rogula, et al.
Life (2021) Vol. 11, Iss. 6, pp. 565-565
Open Access | Times Cited: 4
Anthelmintic agents: vermicide and vermifuge
Gudisa Bereda
Insights in Biology and Medicine (2022) Vol. 6, Iss. 1, pp. 001-008
Open Access | Times Cited: 3
A Review of Potential Therapeutic Strategies for COVID-19
Jiajia Meng, Ruijiao Li, Zhiqi Zhang, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 3
Features of COVID-19 etiopathogenetic pharmacotherapy
Alexandra Romanová, М. А. Абдуллаев, Б. И. Кантемирова, et al.
Medical news of the North Caucasus (2024) Vol. 19, Iss. 1
Open Access
Drug-induced liver injury and COVID-19: Use of artificial intelligence and the updated Roussel Uclaf Causality Assessment Method in clinical practice
Gabriela Xavier Ortiz, Ana Helena Dias Pereira dos Santos Ulbrich, Gabriele Lenhart, et al.
Artificial Intelligence in Gastroenterology (2023) Vol. 4, Iss. 2, pp. 36-47
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top